Financials

  • Market Capitalization 801.9 M
  • Employee 258
  • Founded 1990
  • CEO John A Scarlett
  • Website www.geron.com
  • Headquarter Delaware, United States
  • FIGI BBG000GX1891
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-10.15
Rapporto prezzo/fatturato

Geron Corporation - Common Stock

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

Notizie